{
    "clinical_study": {
        "@rank": "56981", 
        "arm_group": [
            {
                "arm_group_label": "Neopuff group", 
                "arm_group_type": "Experimental", 
                "description": "includes 34 newborns showing signs of TTN who received CPAP (5 cm of H2O) via T- piece (Neopuff; Fisher and Paykel Healthcare, Auckland, New Zealand)."
            }, 
            {
                "arm_group_label": "Control group", 
                "arm_group_type": "No Intervention", 
                "description": "includes 30 newborns who will receive nasal prong oxygen treatment; standard care according to Siva Subramanian et al. (2010)."
            }
        ], 
        "brief_summary": {
            "textblock": "Evaluating the effect of early application of Continuous positive airway pressure (CPAP) via\n      Neopuff in cases of transient tachypnea of the newborn(TTN) and its role in decreasing the\n      duration and complication of TTN."
        }, 
        "brief_title": "Positive End Expiratory Pressure With A T-piece Resuscitator For Near-Term and Term Infants With Respiratory Distress", 
        "completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "condition": "Transient Tachypnea of the Newborn", 
        "detailed_description": {
            "textblock": "The aim of the study is to determine whether positive end expiratory  pressure therapy\n      (PEEP) administered early via a T piece based infant resuscitator (Neopuff) would safely\n      reduce the incidence of TTN and the need for neonatal intensive care unit (NICU) admission\n      of near term and term infants with respiratory distress."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Near term infants (36-37 weeks gestational age) and Full term infants (38-41 weeks\n             gestational age).\n\n          -  Presence of signs of respiratory distress (Tachypnea, intercostal and subcostal\n             retractions, nasal flaring and grunting) evident shortly after birth.\n\n          -  Cesarean section (CS) was defined as elective when surgery was performed before the\n             onset of labor, with all other cases defined as secondary CS.\n\n        Exclusion Criteria:\n\n          -  Presence of any of the risk factors for neonatal sepsis such as Prolonged Rupture of\n             Membranes for \u226548 hours (PROM), maternal fever, maternal chorioamnionitis or positive\n             maternal GBS colonization.\n\n          -  Presence of any other cause of respiratory distress, eg.\n\n               -  congenital malformations affecting the cardiorespiratory system ,\n\n               -  chromosomal aberrations,\n\n               -  depression at birth (Apgar score at 5 minutes of < 7 or umbilical artery pH of <\n                  7.10),\n\n               -  fetal hydrops,\n\n               -  persistent pulmonary hypertension,\n\n               -  and meconium aspiration syndrome."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "2 Days", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "64", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01859533", 
            "org_study_id": "Ain Shams Uni"
        }, 
        "intervention": {
            "arm_group_label": "Neopuff group", 
            "description": "Group I neonates (Experimental group) includes 30 newborns showing signs of TTN who will receive administration of CPAP (5 cm of H2O) via T- piece (Neopuff; Fisher and Paykel Healthcare, Auckland, New Zealand).\nGroup II neonates (Control group) includes 30 newborns who will receive nasal prong oxygen treatment; standard care according to Siva Subramanian et al. (2010).", 
            "intervention_name": "Neopuff", 
            "intervention_type": "Device", 
            "other_name": "Early CPAP"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 20, 2013", 
        "number_of_arms": "2", 
        "official_title": "Positive End Expiratory Pressure With A T-piece Resuscitator (Neopuff) For Near-Term and Term Infants With Respiratory Distress: A Randomized, Controlled Trial", 
        "overall_official": [
            {
                "affiliation": "Associate Professor of Pediatrics, Department of Pediatrics, Ain Shams University, Cairo, Egypt", 
                "last_name": "Rania A. El-Farrash, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Professor of Pediatrics, Department of Pediatrics, Ain Shams University, Cairo, Egypt", 
                "last_name": "Amani O. Mahmoud, MD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Netherlands: Ministry of Health, Welfare and Sports", 
                "last_name": "Enas H. Abdul-Hady, M.B.B.Ch", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Egypt: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Need for admissions to NICU secondary to TTN", 
            "safety_issue": "No", 
            "time_frame": "24 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01859533"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ain Shams University", 
            "investigator_full_name": "Rania Ali El-Farrash", 
            "investigator_title": "Lecturer of Pediatrics", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Levels of plasma brain natriuretic peptide and clinical outcome [Time Frame: 24 hours].", 
                "safety_issue": "No", 
                "time_frame": "24 hours"
            }, 
            {
                "measure": "Duration of tachypnea.", 
                "safety_issue": "No", 
                "time_frame": "until discharge"
            }, 
            {
                "measure": "Duration and type of oxygen therapy.", 
                "safety_issue": "No", 
                "time_frame": "ntil discharge"
            }, 
            {
                "measure": "Antibiotic treatment.", 
                "safety_issue": "No", 
                "time_frame": "until discharge"
            }, 
            {
                "measure": "Incidence of pulmonary air leaks", 
                "safety_issue": "Yes", 
                "time_frame": "ntil discharge"
            }, 
            {
                "measure": "Length of hospital (NICU) stay", 
                "safety_issue": "No", 
                "time_frame": "until discharge"
            }, 
            {
                "measure": "Death", 
                "safety_issue": "No", 
                "time_frame": "until discharge"
            }
        ], 
        "source": "Ain Shams University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ain Shams University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}